皮塔瓦斯塔丁减轻了高胆固醇血清症引起的血清素载体可用性的下降
Sy-Jou Chen1, Rou-Ling Cho2, Skye Hsin-Hsien Yeh3,4
1Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan. syjou.chen@gmail.com.
Lipids in health and disease
|August 17, 2024
概括
皮塔瓦斯塔丁可以降低高胆固醇贫血小鼠的胆固醇和炎症. 它还增强了血清素载体 (SERT) 的可用性,可能缓解抑郁症状.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 心血管研究研究心血管研究
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 高胆固醇血症与炎症增加和血清素神经递质受损有关,可能导致抑郁症状.
- 像皮塔瓦斯塔丁这样的他类药物对高胆固醇血清症中血清素输送体 (SERT) 功能的特定影响尚不清楚.
- 这项研究调查了皮塔瓦斯塔丁在抵消高胆固醇血清症的神经生物学影响方面的潜力.
研究的目的:
- 评估皮塔瓦斯塔丁在高胆固醇血症小鼠模型中的神经生物学效应.
- 为了确定皮塔瓦斯塔丁是否可以调节高胆固醇和炎症的背景下,血清素转运体 (SERT) 的可用性.
- 评估皮塔瓦斯塔丁对脂质特征,炎症标志物和类似抑郁的行为的影响.
主要方法:
- 使用低密度脂蛋白受体淘汰 (LDLR-/-) 的小鼠吃了标准饮食,高脂肪饮食 (HFD) 或补充皮塔瓦斯塔丁的HFD.
- 在20周内评估脂质样本和炎症标志物 (IL-1α,MCP-1/CCL2,TNF-α).
- 使用4-[18F]-ADAM的小动物正子发射断层扫描 (PET) 来测量大脑区域中血清素载体 (SERT) 的可用性.
主要成果:
- 皮塔瓦斯塔丁显著降低了HFD养小鼠的总和LDL胆固醇.
- 皮塔瓦斯塔丁治疗增加的炎症标志物减少.
- PET成像显示,HFD小鼠的SERT可用性降低,皮塔瓦斯塔丁可以改善这种情况,特别是在与情绪相关的大脑区域. 糖糖偏好显示出改善的趋势,表明抑郁症类行为减少.
结论:
- 皮塔瓦斯塔丁证明了多方面的益处,降低胆固醇和减少炎症.
- 该药物增强了血清素载体 (SERT) 的可用性,表明在情绪调节中具有潜在的治疗作用.
- 这些发现表明皮塔瓦斯塔丁可能有助于缓解与高胆固醇血症相关的抑郁症状.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
230
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
230
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
604
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
604
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
104
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
339
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
339
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209


